|
[posting]61166882[/posting]Sorry, der Link funktioniert nicht richtig.... Bin kein Profi! Ich kopiere: Zacks: Analysts Anticipate Galena Biopharma, Inc. (NYSE:SLS) Will Post Earnings of -$0.18 Per Share https://dakotafinancialnews.com/2019/08/01/zacks-analysts-an… Equities research analysts predict that Galena Biopharma, Inc. (NYSE:SLS) will announce ($0.18) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Galena Biopharma’s earnings. Galena Biopharma posted earnings of ($1.26) per share in the same quarter last year, which indicates a positive year over year growth rate of 85.7%. The business is scheduled to issue its next quarterly earnings report on Wednesday, August 21st. On average, analysts expect that Galena Biopharma will report full year earnings of ($0.85) per share for the current financial year. For the next financial year, analysts expect that the business will post earnings of ($0.99) per share. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover Galena Biopharma. so Vorschau sieht gut aus.... Jetzt glaube ich besser................ |
|
| aus der Diskussion: | Sellas Life Sciences Group (ehemals Galena Biopharma) |
| Autor (Datum des Eintrages): | ToBeDoo (03.08.19 11:56:36) |
| Beitrag: | 2,567 von 2,935 (ID:61166915) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |